
Extended Study Highlights Persistent Retinal Drying and Vision Enhancement with Roche’s Vabysmo in Retinal Vein Occlusion
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new 72-week data from two global Phase III studies, BALATON and COMINO, evaluating Vabysmo® (faricimab) in macular edema due to branch and central…












